An interventional study of simulated training and traditional bedside teaching in Transbronchial Lung Cryobiopsy, sponsored by China-Japan Friendship Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-10.
Sponsored by China-Japan Friendship Hospital · Not applicable, Interventional, and Other
The aim of this study was to conduct a prospective randomized controlled trial to design simulator and in vitro lung standardized training, to perform a learning curve evaluation of transbronchial lung cryobiopsy (TBLC) operating physicians, and to assess the role of standardized training in TBLC.
3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.
This study's planned enrollment of 20 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.
Browse Lung Diseases studies →China-Japan Friendship Hospital is the lead sponsor of 173 studies on the registry; 109 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The bronchoscopists in this group will accept simulation training by means of simulators and extracorporeal lungs
Other: simulated training
The bronchoscopists in this group will accept traditional lectures, hands-on demonstrations and so on to learn TBLC
Other: traditional bedside teaching
Simulation training of bronchoscopists by means of simulators and extracorporeal lungs
TBLC training for bronchoscopists through traditional lectures, hands-on demonstrations
Obtain pathologic quality assessment of specimens
The quality of TBLC sampling specimens was scored by two professional pathologists on a specialized pathology scale.
Time frame: 1 month
histopathological pattern diagnosis rate
Diagnosis of histopathological patterns was performed by two specialized pathologists to determine a consistent diagnostic rate.
Time frame: 1 month
diagnostic rate of multidisciplinary discussions
Diagnostic rates based on composite TBLC, BAL, clinical and imaging data in a multidisciplinary discussion by clinical experts
Time frame: 1 month
Occurrence of short-term adverse events
bleeding and pneumothorax occurred with 24 hours after TBLC, acute exacerbation of ILD and death occurred with 7 days after TBLC
Time frame: 24 hours or 7 days
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China-Japan Friendship Hospital